source
- AI can transform drug discovery only when its strengths are properly leveragedThe article notes a split narrative in the industry, with some headlines promising AI will speed drugs to market while others warn it could waste resources. Thomas M. Kaiser, a medicinal chemist,…
- Four CDMOs to watch as biopharma outsourcing growsThe article lists four contract development and manufacturing organizations (CDMOs) that biopharma companies can partner with as demand for external development and manufacturing rises. Lonza, bas…